Live Quote · NASDAQELVNHealthcare· Biotechnology

Enliven Therapeutics, Inc.

$46.53▲ 0.26%(+$0.12)
MKT CAP $3.42BNEXT EARNINGS Mar 2, 2027
50%
Bullish
TickerSpark Score
57/100
▌ Mixed
50
Valuation
20
Profitability
30
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ELVN research report →

Analyst Price Target
$76.29+64.0% vs. today

Range $70 – $82

Analyst RatingBuy
9 Buy0 Hold0 Sell

Price Chart

+118.76% · this period
$61.15$38.14$15.14Nov 20May 26Nov 20
52-Week Range67% of range
Low
$14.79
Current
$46.53
High
$62.32